This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Dr. Majumdar notes that many Indian states already invest in these areas. Hence, private investments will likely increase soon. Initially, growth may slow slightly in fiscal 2025-2026 to between 6.5 The country continues to attract international investment. Clean energy projects attract significant investments frequently.
These trends make cancer-focused pharma stocks a compelling investment opportunity in India. Future Outlook Beta Drugs plans to broaden its product portfolio as it is planning to launch 25 new products by 2026. Beta Drugs is also focusing on enhancing its sales to 450+ crores by 2026. higher from its previous close of Rs.
Chief Executive Albinder Dhindsa has also announced that Blinkit aims to have 2,000 dark stores by the end of 2026. Written By: Santhosh Disclaimer The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in Investing in equities poses a risk of financial losses.
This expansion aligns with the growing demand for solar energy solutions in India and globally, targeting a market expected to reach $223 billion by 2026. Written By Fazal Ul Vahab Disclaimer The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in
million is predicted to rise at a CAGR of 18% – 20% between Fiscal 2023 and Fiscal 2026. This means the company is managing a larger pool of assets, such as loans, investments, and other financial products, indicating an expansion in business Their revenues follow a similar trend, it has increased from ₹511.53 million to 3.00
If instead, you worked through the 15 th , the “year after retirement” would be 2026. Cordant, Inc. (“Cordant”) is a registered investmentadvisor. The reason January 15 th matters: If, for example, you retired on the 14 th of 2025, the “year after retirement” for SERPLUS would still be 2025.
annualized growth rate as healthy consumer spending helped offset a decline in business investment and a slowdown in nonresidential investment. The business inventory investment slowdown reduced the headline GDP number by 2.26%. The return and principal value of investments will fluctuate as market conditions change.
We organize all of the trending information in your field so you don't have to. Join 36,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content